Galafold 123 MG
Ended Awarded
- Contract number
- 36C24525N0634
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,891
Award facts
- Contract value 100% obligated
- $21,891.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., a biopharmaceutical company focused on developing treatments for rare genetic diseases. The contract, valued at $21,891.21, is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) for the pharmaceutical product Galafold (migalastat) 123 mg, an enzyme replacement therapy used to treat Fabry disease. The contract has an ultimate completion date of May 16, 2025, and was awarded on May 14, 2025. Amicus Therapeutics US, LLC holds a larger Federal Supply Schedule (FSS) contract with the VA, valued at $13,024,630, which enables various VA Veterans Integrated Service Networks to place task orders for Galafold. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C24525N0634?
36C24525N0634 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on May 14, 2025.
How much is contract 36C24525N0634 worth?
The government has obligated $21,891 on 36C24525N0634.
Is contract 36C24525N0634 an order under another contract?
Yes. 36C24525N0634 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0634 competed?
The extent of competition for 36C24525N0634 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award